Latest Period
Q4 2025
Security Snapshot
Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) Institutional Ownership
CUSIP: M40527109
13F Institutional Holders and Ownership History from Q2 2018 to Q1 2026
Institutions Reporting
21
Shares (Excl. Options)
9,323,742
Price
$1.94
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Ordinary shares, par value NIS 0.0000769 per share
- Symbol
- ENTX on Nasdaq
- Shares outstanding
- 45,504,462
- Price per share
- $1.11
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 9,323,742
- Total reported value
- $18,087,991
- % of total 13F portfolios
- 0%
- Share change
- -1,479
- Value change
- +$502
- Number of holders
- 21
- Price from insider filings
- $1.11
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share is tracked under CUSIP M40527109.
- 21 institutions reported positions in Q4 2025.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 21 to 5 between Q4 2025 and Q1 2026.
- Reported value moved from $18,087,991 to $108,082.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 21 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP M40527109?
CUSIP M40527109 identifies ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP M40527109:
Significant Owners of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| OPKO HEALTH, INC. | 8.1% | $8,660,281 | 3,685,226 | OPKO HEALTH, INC. | 16 Mar 2025 | |||
| Point72 Asset Management, L.P. | 2.6% | -60% | $2,271,583 | -$2,915,412 | 1,183,116 | -56% | Point72 Asset Management, L.P. | 30 Sep 2025 |
As of 31 Dec 2025, 21 institutional investors reported holding 9,323,742 shares of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX). This represents 20% of the company’s total 45,504,462 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) together control 20% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Knoll Capital Management, LLC | 13% | 5,881,879 | 0% | 5.2% | $11,410,845 |
| Point72 Asset Management, L.P. | 2.6% | 1,193,653 | +1.3% | 0% | $2,315,687 |
| MARSHALL WACE, LLP | 1.4% | 627,330 | 0% | 0% | $1,217,020 |
| Schonfeld Strategic Advisors LLC | 1.3% | 596,585 | +5.2% | 0.01% | $1,157,374 |
| Parkman Healthcare Partners LLC | 0.6% | 275,073 | -2% | 0.05% | $533,642 |
| NORTHERN TRUST CORP | 0.33% | 148,668 | 0% | 0% | $288,416 |
| Seven Fleet Capital Management LP | 0.3% | 135,318 | 0% | 0.18% | $262,517 |
| RENAISSANCE TECHNOLOGIES LLC | 0.24% | 108,001 | +22% | 0% | $209,522 |
| JANE STREET GROUP, LLC | 0.16% | 74,064 | +143% | 0% | $143,685 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.14% | 64,910 | -3.4% | 0% | $125,925 |
| SIGNATURE ESTATE & INVESTMENT ADVISORS LLC | 0.1% | 47,328 | 0% | 0% | $91,816 |
| HighTower Advisors, LLC | 0.09% | 43,140 | +138% | 0% | $83,692 |
| CITADEL ADVISORS LLC | 0.09% | 40,230 | +0.63% | 0% | $78,046 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.05% | 21,136 | 0% | 0% | $41,003 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.04% | 17,142 | 0.02% | $33,255 | |
| BANK OF AMERICA CORP /DE/ | 0.03% | 15,000 | -29% | 0% | $29,100 |
| GOLDMAN SACHS GROUP INC | 0.03% | 12,327 | 0% | $23,914 | |
| GSA CAPITAL PARTNERS LLP | 0.03% | 11,890 | 0% | $23,000 | |
| PNC Financial Services Group, Inc. | 0.02% | 10,000 | 0% | 0% | $19,400 |
| GROUP ONE TRADING LLC | 0% | 51 | 0% | 0% | $99 |
| UBS Group AG | 0% | 17 | -100% | 0% | $33 |
| XTX Topco Ltd | 0% | 0 | -100% | $0 | |
| BESSEMER GROUP INC | 0% | 0 | -100% | $0 | |
| SBI Securities Co., Ltd. | 0% | 0 | -100% | $0 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0% | 0 | -100% | $0 |
Institutional Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 97,372 | $108,082 | -$26,456 | $1.11 | 5 |
| 2025 Q4 | 9,323,742 | $18,087,991 | +$502 | $1.94 | 21 |
| 2025 Q3 | 9,194,576 | $17,653,167 | -$1,951,360 | $1.92 | 21 |
| 2025 Q2 | 10,211,002 | $19,401,301 | +$12,863 | $1.90 | 19 |
| 2025 Q1 | 10,222,258 | $17,377,838 | +$4,637,662 | $1.70 | 18 |
| 2024 Q4 | 7,494,222 | $15,902,006 | +$4,661,706 | $2.12 | 14 |
| 2024 Q3 | 5,323,228 | $10,112,228 | +$57,454 | $1.90 | 17 |
| 2024 Q2 | 5,292,989 | $9,745,202 | +$1,916,835 | $1.84 | 14 |
| 2024 Q1 | 4,259,308 | $7,113,387 | +$404,057 | $1.67 | 14 |
| 2023 Q4 | 4,062,589 | $2,437,015 | +$887,868 | $0.60 | 9 |
| 2023 Q3 | 2,579,003 | $1,870,234 | +$4,206 | $0.72 | 11 |
| 2023 Q2 | 2,569,162 | $2,166,115 | -$314,934 | $0.84 | 10 |
| 2023 Q1 | 2,830,846 | $3,283,550 | -$215,433 | $1.16 | 8 |
| 2022 Q4 | 566,752 | $413,272 | -$1,176,817 | $0.73 | 10 |
| 2022 Q3 | 4,663,496 | $4,850,000 | -$254,655 | $1.04 | 8 |
| 2022 Q2 | 4,916,394 | $6,538,000 | -$45,964 | $1.33 | 9 |
| 2022 Q1 | 4,949,328 | $14,203,000 | -$2,021,499 | $2.86 | 10 |
| 2021 Q4 | 5,655,346 | $15,920,000 | -$38,159 | $2.82 | 10 |
| 2021 Q3 | 5,665,990 | $26,717,000 | +$2,489,496 | $4.71 | 13 |
| 2021 Q2 | 5,111,468 | $30,566,000 | +$18,924,636 | $5.98 | 14 |
| 2021 Q1 | 1,986,053 | $7,567,000 | +$563,572 | $3.81 | 7 |
| 2020 Q4 | 1,857,733 | $2,008,000 | -$82,677 | $1.09 | 5 |
| 2020 Q3 | 1,905,237 | $2,363,000 | -$160,746 | $1.24 | 5 |
| 2020 Q2 | 1,950,079 | $3,422,000 | -$82,244 | $1.83 | 5 |
| 2020 Q1 | 1,990,244 | $3,781,000 | +$137,000 | $1.99 | 3 |
| 2019 Q4 | 1,921,509 | $3,990,000 | +$1,633,552 | $2.07 | 3 |
| 2019 Q3 | 1,054,649 | $2,624,000 | -$28,428 | $2.49 | 5 |
| 2019 Q2 | 1,065,733 | $3,492,000 | -$119,087 | $3.26 | 6 |
| 2019 Q1 | 1,087,864 | $4,669,000 | +$276,172 | $4.32 | 7 |
| 2018 Q4 | 1,025,992 | $3,100,000 | +$768,525 | $3.05 | 5 |
| 2018 Q3 | 768,625 | $4,108,000 | +$250,730 | $5.63 | 4 |
| 2018 Q2 | 725,479 | $4,571,000 | +$4,571,000 | $6.30 | 3 |